BREAKING NEWS

US FDA delays decision on Moderna's COVID-19 vaccine for adolescents

The US health regulator is delaying a decision on authorizing Moderna Inc's COVID-19 vaccine for adolescents to assess whether the shot may lead to heightened risk of heart inflammation, the Wall Street Journal reported on Friday, citing people familiar with the matter.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy